Literature DB >> 1259456

Hereditary tyrosinaemia. Clinical, enzymatic, and pathological study of an infant with the acute form of the disease.

N A Carson, J D Biggart, A H Bittles, D Donovan.   

Abstract

A clinical, enzymatic, and pathological study of an infant with the acute form of hereditary tyrosinaemia is presented. Treatment with a diet low in methionine, tyrosine, and phenylalanine was unsuccessful. A selection of specific and nonspecific hepatic enzymes, obtained at necropsy within one hour of the infant's death at 9 1/2 weeks, were studied to try to throw light on the basic defect. The major pathological findings were those of a peculiar hepatic fibrosis associated with bile retention and an abnormal grouping of hepatocytes, islet-cell hyperplasia of the pancreas, and dilatation of the proximal renal tubules. Death was precipitated by bronchopneumonia and liver failure. The difficulty in diagnosing the acute form of tyrosinaemia is pointed out, especially in differentiating it from hereditary galactosaemia (transferase deficiency) and hereditary fructosaemia. All three may present with the same clinical symptoms and liver lesions, and the distinction must be made by enzyme studies and by therapeutic trial.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1259456      PMCID: PMC1545902          DOI: 10.1136/adc.51.2.106

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  22 in total

1.  Fructose-1,6-diphosphatase deficiency: another enzyme defect which can present itself with the clinical features of "tyrosinosis".

Authors:  H D Bakker; P K de Bree; F J van Sprang; S K Wadman
Journal:  Clin Chim Acta       Date:  1974-08-30       Impact factor: 3.786

2.  Biochemical observations on so-called hereditary tyrosinemia.

Authors:  G E Gaull; D K Rassin; G E Solomon; R C Harris; J A Sturman
Journal:  Pediatr Res       Date:  1970-07       Impact factor: 3.756

3.  Hereditary tyrosinemia with hyperplasia and hypertrophy of juxtaglomerular apparatus.

Authors:  M M Jevtic; F K Thorp; Z Hruban
Journal:  Am J Clin Pathol       Date:  1974-03       Impact factor: 2.493

4.  Temporary tyrosinosis.

Authors:  D Pickering; B Bower
Journal:  Arch Dis Child       Date:  1972-02       Impact factor: 3.791

5.  Neonatal hepatitis in premature infants simulating hereditary tyrosinosis.

Authors:  J S Yu; J A Walker-Smith; E D Burnard
Journal:  Arch Dis Child       Date:  1971-06       Impact factor: 3.791

6.  The free amino acids in human cerebrospinal fluid.

Authors:  M van Sande; Y Mardens; K Adriaenssens; A Lowenthal
Journal:  J Neurochem       Date:  1970-02       Impact factor: 5.372

7.  Hereditary tyrosinemia. 3. On the differential diagnosis and the lack of effect of early dietary treatment.

Authors:  G Bodegård; J Gentz; B Lindblad; S Lindstedt; R Zetterström
Journal:  Acta Paediatr Scand       Date:  1969-01

8.  Enzyme activity in the liver and serum of malnourished children in Jamaica.

Authors:  A E McLean
Journal:  Clin Sci       Date:  1966-02       Impact factor: 6.124

9.  Experience with 37 infants with tyrosinemia.

Authors:  J Larochelle; A Mortezai; M Belanger; M Tremblay; J C Claveau; G Aubin
Journal:  Can Med Assoc J       Date:  1967-10-28       Impact factor: 8.262

10.  Tyrosinosis (inborn hepato-renal dysfunction).

Authors:  L I Woolf
Journal:  Proc R Soc Med       Date:  1966-09
View more
  4 in total

1.  Haemorrhagic diathesis as a possible early sign of hereditary fructose intolerance.

Authors:  A Hosková; A Mrskos
Journal:  Eur J Pediatr       Date:  1977-12-30       Impact factor: 3.183

2.  Acute hereditary tyrosinaemia type I: clinical, biochemical and haematological studies in twins.

Authors:  R G Gray; A D Patrick; F E Preston; M F Whitfield
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

3.  Visceral pathology of hereditary tyrosinemia type I.

Authors:  P Russo; S O'Regan
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

Review 4.  Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations.

Authors:  Jeffrey M Chinsky; Rani Singh; Can Ficicioglu; Clara D M van Karnebeek; Markus Grompe; Grant Mitchell; Susan E Waisbren; Muge Gucsavas-Calikoglu; Melissa P Wasserstein; Katie Coakley; C Ronald Scott
Journal:  Genet Med       Date:  2017-08-03       Impact factor: 8.822

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.